NCT06953024Terminated
Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
This study aims to validate the percent agreement of the INSTI Multiplex Human Immunodeficiency (HIV) 1/2 syphilis antibody (Ab) test (INSTI POCT) when used as a self-test by patients compared to conventional serologic testing.
- Status (registry)
- Terminated
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 17 Apr 2025
- Start date
- 6 Oct 2025
- Primary completion date
- 18 Dec 2025
- Lead sponsor
- Nova Scotia Health Authority
- Diseases
- HIV
- NCT number
- NCT06953024
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to speak and understand English
Criteria the registry did not label
- Branch #1: Participants known to have an HIV infection - Inclusion criteria:
- Previously documented positive HIV serology
- Branch #2: Participants known to have a history of syphilis infection - Inclusion criteria:
- Documented positive syphilis serology
- Branch #3: Participants with no known HIV or syphilis infections - Inclusion criteria:
- No documented positive HIV or syphilis serology
Age in the registry: 15 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| QEII STI Clinic Coordinator of this site? Confirm its status | Halifax | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.